Long-term remission of severe psoriasis following CD19-direc…

Emerging


1
Citations
11
Refs
2026
Year
Search Works
Work Details
  • DOI 10.1093/ced/llag301
  • PMID https://pubmed.ncbi.nlm.nih.gov/42462170
  • OpenAlex ID W7168748606
  • Type Article
  • Language EN
  • Published 15 Jul 2026
  • Volume 51 (11)
  • Pages 2089–2092
  • Source Clinical and Experimental Dermatology
  • Publisher Oxford University Press
  • FWCI 2.70
  • Countries 3
  • Institutions 9
  • Added 17 Jul 2026
  • Updated 28 Oct 2026
MENU
0

Long-term remission of severe psoriasis following CD19-directed chimeric antigen receptor T-cell therapy for follicular lymphoma

Article 2026 EN Hybrid

Psoriasis is a chronic, immune-mediated inflammatory disease in which durable, treatment-free remission is rarely achieved despite highly effective biologic therapies. We report a 60-year-old woman with a 49-year history of severe plaque psoriasis who developed complete and sustained disease clearance following autologous CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy for follicula…

1

Citations

11

References

9

Authors

2.70

FWCI

Citations by Year
Last 1 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
9 authors
#AuthorInstitutionsORCID
1 Wayne P. F. Gulliver Memorial University of Newfoun… (CA)
2 Jonah Wiseman Perlmutter University of Toronto (CA)
3 Susanne R. Gulliver —
4 George‐Sorin Ţiplica Carol Davila University of Med… (RO)
5 Charles W Lynde University of Toronto (CA) Lynde Centre for Dermatology (CA)
6 Robert Gniadecki University of Alberta (CA)
7 Harold L. Atkins Ottawa Hospital (CA)
8 Christopher E.M. Griffiths King's College London (GB) King's College Hospital (GB)
9 Su M. Lwin Corresponding King's College London (GB) Guy's and St Thomas' NHS Found… (GB)

Data: OpenAlex